文献速递肝病

生活质量下降与非酒精性脂肪性肝病患者的身体成分显著相关

Decreased Quality of Life Is Significantly Associated With Body Composition in Patients With Nonalcoholic Fatty Liver Disease.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-04-29

研究纳入341例非酒精性脂肪性肝病患者,用SF-36问卷评估生活质量,用生物电阻抗和瞬时弹性成像评估身体成分和肝纤维化。发现体脂百分比与全部8个SF-36量表得分负相关,瘦体重与5个量表得分正相关;即使无进展性纤维化,患者生活质量也显著低于对照和一般人群。

要点

  • 非酒精性脂肪性肝病患者体脂百分比与全部8个SF-36量表得分负相关。
  • 瘦体重与8个SF-36量表中的5个得分正相关。
  • 即使无进展性纤维化,患者生活质量也显著低于对照和一般人群。

核心结论

  • 非酒精性脂肪性肝病患者即使无进展性纤维化,生活质量也低于对照。
  • 身体成分与生活质量相关,两个可干预因素均与身体成分有关。
  • 需进一步研究改善身体成分的干预能否提高患者生活质量。

研究设计与样本

  • 收集341例完成SF-36问卷的非酒精性脂肪性肝病患者数据。
  • 用生物电阻抗评估身体成分,用瞬时弹性成像评估肝纤维化。
  • 进展性纤维化定义为肝硬度值≥12.1 kPa。
  • 将患者SF-36得分与文献中慢性病患者和一般人群的得分比较。

主要发现

  • 体脂百分比与全部8个SF-36量表得分负相关。
  • 瘦体重与8个SF-36量表中的5个得分正相关。
  • 多变量分析中SF-36 PF得分与2型糖尿病、体质指数和肝硬度值负相关,与瘦体重和丙氨酸氨基转移酶水平正相关。
  • 患者即使无进展性纤维化,平均生活质量得分也显著低于对照组或一般人群。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: We studied impaired quality of life (QOL) and its determinants among individuals with nonalcoholic fatty liver disease (NAFLD). METHODS: We collected data from 341 patients with NAFLD who completed the short form 36 (SF-36) questionnaire. Body composition and liver fibrosis were assessed in patients with NAFLD using bioelectrical impedance and transient elastography, respectively. Advanced fibrosis was defined as liver stiffness measurements (LSMs) of 12.1 kPa or greater. SF-36 scores of patients with NAFLD were compared with SF36 scores of individuals with chronic medical illnesses and the general population obtained from the published literature. RESULTS: Among patients with NAFLD, percent body fat was negatively associated with scores from all 8 SF-36 scales, whereas lean body mass was positively associated with scores from 5 of 8 SF-36 scales. On multivariable analysis, SF-36 PF scores were negatively associated with type 2 diabetes, body mass index, and LSM and positively associated with lean body mass and level of alanine aminotransferase. Patients with NAFLD, and even those without advanced fibrosis, had significantly lower mean QOL scores than the control group or the general population. CONCLUSIONS: Individuals with NAFLD, even those without advanced fibrosis, have lower QOL than controls. Body composition associates with QOL in patients with NAFLD; both of the modifiable factors independently associated with QOL are related to body composition. Further studies are needed to investigate if interventions to improve body composition can increase QOL for patients with NAFLD.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Samala N, Desai A, Vilar-Gomez E, et al. Decreased Quality of Life Is Significantly Associated With Body Composition in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2020. PMID: 32360826. doi:10.1016/j.cgh.2020.04.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。